Endoscopic calcium electroporation in patients with precancerous cellular changes in the esophagus
European Journal of Surgical Oncology · 2025
DOI: 10.1016/j.ejso.2025.110290 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Surgical Oncology, 2025. Verfasst von Laser Arif Bazancir und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Digestive Diseases, Transplantation and General Surgery, Rigshospitalet, University of Copenhagen, Denmark. Electronic address: laser.a…. Hauptthemen laut MEDLINE: Barrett Esophagus, Precancerous Conditions, Esophageal Neoplasms, Calcium. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Danish Cancer Society.
Abstract (Originalsprache)
BACKGROUND: Barrett's esophagus high-grade dysplasia (BE HGD) can transform into esophageal adenocarcinoma (EAC) in 19-28 % of the cases. Calcium electroporation (Ca-EP) is a novel anti-cancer therapy where electrical pulses are combined with a local injection of calcium to increase intracellular calcium levels leading to cell death. Calcium electroporation has shown effect on premalignant conditions, and a relative sparing of normal tissue. METHODS: The primary aim of this study was to establish safety with Ca-EP in patients with BE HGD. Six patients with BE HGD scheduled for an endoscopic submucosal dissection (ESD) were treated with Ca-EP six weeks before under general anesthesia in an outpatient setting. All adverse events (AEs) were registered, and patients were evaluated with gastroscopy within one week. RESULTS: AEs included retrosternal pain, throat irritation, coughing, and headache. No serious adverse events were registered. A hyperemic area was seen in four patients directly after Ca-EP. Fibrinous coatings (four patients) and ulcers (four patients) were observed up to one week after treatment. One patient underwent two CTA scans due to pain and a visually large fibrinous clot. CTA showed no sign of perforation. Six weeks after five patients had a partial visual response with new squamous epithelium. However, all patients still had BE HGD. CONCLUSION: Ca-EP was safe in patients with BE HGD. This study paves the way for more extensive studies to investigate the effect on dysplastic cells and its role in treating esophageal adenocarcinoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Digestive Diseases, Transplantation and General Surgery, Rigshospitalet, University of Copenhagen, Denmark. Electronic address: laser.arif.bazancir@regionh.dk.
- Department of Digestive Diseases, Transplantation and General Surgery, Rigshospitalet, University of Copenhagen, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen…
- Department of Pathology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
- Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; Center for Experimental Drug and Gene Electrotransfer (C∗EDGE), Department of Clinical Oncology and…
Förderung
- Danish Cancer Society
Zitieren
APA
Bazancir, L. A., Egeland, C., Garbyal, R. S., Gehl, J., & Achiam, M. P. (2025). Endoscopic calcium electroporation in patients with precancerous cellular changes in the esophagus. European Journal of Surgical Oncology. https://doi.org/10.1016/j.ejso.2025.110290
Vancouver
Bazancir LA, Egeland C, Garbyal RS, Gehl J, Achiam MP. Endoscopic calcium electroporation in patients with precancerous cellular changes in the esophagus. European Journal of Surgical Oncology. 2025. doi:10.1016/j.ejso.2025.110290
BibTeX
@article{Bazancir2025,
author = {Bazancir, Laser Arif and Egeland, Charlotte and Garbyal, Rajendra Singh and Gehl, Julie and Achiam, Michael Patrick},
title = {Endoscopic calcium electroporation in patients with precancerous cellular changes in the esophagus},
journal = {European Journal of Surgical Oncology},
year = {2025},
doi = {10.1016/j.ejso.2025.110290}
}
EUVIMED